Provalis Files G5 Diabetes Test with FDA and Builds USA Sales Team DEESIDE, U.K., June 17, 2004 (PRIMEZONE) -- Provalis plc (LSE:PRO) (Nasdaq:PVLS), the Medical Diagnostics and Pharmaceuticals Group, is pleased to announce that, on schedule, it has filed the USA...